APOA1 and type 2 diabetes mellitus: To delve further and relate our findings for ApoA-I priming with these receptors to human physiology, we explored publicly available β-cell expression data from human donors with (n = 5) and without (n = 6) type 2 diabetes (GSE153855) [19].